يعرض 1 - 10 نتائج من 35 نتيجة بحث عن '"Hernando Cubero, Jorge"', وقت الاستعلام: 1.82s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Baraibar I, Salvà F, Ros J, Saoudi N, García-Álvarez A, Hernando J, Capdevila J, Castells MR, Tabernero J, Élez E Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. García A, Comas R, Castillo G, Sanchis M Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Martí M, Espín E, Dopazo C Servei de Cirurgia General i Digestiva, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Landolfi S Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Navalpotro B Servei d’Oncologia Radioteràpica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Guevara J Servei d’Aparell Digestiu, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Nuciforo P, Vivancos A Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Translational Oncology;32; https://doi.org/10.1016/j.tranon.2023.101668Test; Baraibar I, García A, Salvà F, Ros J, Saoudi N, Comas R, et al. Impact of the COVID-19 pandemic in the early-onset colorectal cancer. Transl Oncol. 2023 Jun;32:101668.; https://hdl.handle.net/11351/9430Test; 000866211600326

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Mitjavila M Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. Jimenez-Fonseca P Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain. Belló P Department of Nuclear Medicine, Hospital Universitario La Fe, Valencia, Spain. Pubul V Department of Nuclear Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain. Percovich JC Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain. Garcia-Burillo A Servei de Medicina Nuclear, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hernando J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: European Journal of Nuclear Medicine and Molecular Imaging;50; https://doi.org/10.1007/s00259-023-06166-8Test; Mitjavila M, Jimenez-Fonseca P, Belló P, Pubul V, Percovich JC, Garcia-Burillo A, et al. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study. Eur J Nucl Med Mol Imaging. 2023 Jul;50:2486–500.; https://hdl.handle.net/11351/9825Test; 000951227100001

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Capdevila J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medical Oncology Department, IOB-Quiron-Teknon, Barcelona, Spain. Hernando J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Teule A Medical Oncology Department, Institut Català d’Oncologia (ICO) - IDIBELL L’Hospitalet del Llobregat, L’Hospitalet de Llobregat, Spain. Lopez C Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. Garcia-Carbonero R Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, UCM, CNIO, Madrid, Spain. Benavent M Medical Oncology Department, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain. Landolfi S Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERONC, Barcelona, Spain. Nuciforo P Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Nature Communications;14; https://doi.org/10.1038/s41467-023-38611-5Test; Capdevila J, Hernando J, Teule A, Lopez C, Garcia-Carbonero R, Benavent M, et al. Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin. Nat Commun. 2023 May 23;14:2973.; https://hdl.handle.net/11351/9654Test

  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Agència de Gestió d'Ajuts Universitaris i de Recerca 2014-SGR-474; Agència de Gestió d'Ajuts Universitaris i de Recerca 2017-SGR-1174; Instituto de Salud Carlos III PI13/01728; Instituto de Salud Carlos III PI19/00740; Clinical & Translational Oncology; Vol. 24 Núm. 11 (november 2022), p. 2155-2165; https://ddd.uab.cat/record/275177Test; urn:10.1007/s12094-022-02868-x; urn:oai:ddd.uab.cat:275177; urn:scopus_id:85132869470; urn:articleid:16993055v24n11p2155; urn:pmid:35761123; urn:pmc-uid:9522782; urn:pmcid:PMC9522782; urn:oai:pubmedcentral.nih.gov:9522782

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Garcia-Alvarez A, Hernando J, Carmona-Alonso A, Capdevila J Unitat de Tumors Gastrointestinals i Endocrins, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Endocrinology;13; https://doi.org/10.3389/fendo.2022.929091Test; Garcia-Alvarez A, Hernando J, Carmona-Alonso A, Capdevila J. What is the status of immunotherapy in thyroid neoplasms? Front Endocrinol. 2022 Aug 5;13:929091.; https://hdl.handle.net/11351/8342Test; 000842917900001

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Muñoz de Nova JL, Martín-Pérez E Department of General and Digestive Surgery, Hospital Universitario de La Princesa, Madrid 28006, Spain. Department of Surgery, Universidad Autónoma de Madrid, Madrid 28029, Spain. Hernando J, Capdevila J Tumors Gastrointestinals i Endocrins, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Sampedro Núñez M Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Madrid 28006, Spain. Vázquez Benítez GT Department of Pathology, Hospital Universitario Puerta de Hierro, Madrid 28222, Spain. Department of Pathology, Universidad Autónoma de Madrid, Madrid 28029, Spain. Triviño Ibáñez EM Department of Nuclear Medicine, Virgen de las Nieves University Hospital, Granada 18014, Spain. Del Olmo García MI Department of Endocrinology and Nutrition, Hospital Universitario i Politècnic La Fe, Valencia 46023, Spain. Barriuso J Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, United Kingdom. Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: World journal of gastroenterology;28(13); http://dx.doi.org/10.3748/wjg.v28.i13.1304Test; Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, Del Olmo García MI, et al. Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. World J Gastroenterol. 2022 Apr 7;28(13):1304–14.; https://hdl.handle.net/11351/8075Test; 000797337500002

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Cives M Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy. Hernando J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Lamarca A Department of Medical Oncology, The Christie NHS Foundation, Manchester, Division of Cancer Sciences, University of Manchester, Manchester, UK. Bouvier C International Neuroendocrine Cancer Alliance (INCA), Boston, Massachusetts, USA. Caplin M Neuroendocrine Tumor Unit, Royal Free Hospital, London, UK. Pavel M Department of Medicine 1, Endocrinology, Friedrich Alexander Universität ErlangenNürnberg, Erlangen, Germany, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal of Neuroendocrinology;34(10); https://doi.org/10.1111/jne.13196Test; Cives M, Hernando J, Lamarca A, Bouvier C, Caplin M, Pavel M, et al. The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients. J Neuroendocrinol. 2022 Oct;34(10):e13196.; https://hdl.handle.net/11351/8401Test; 000850714900001

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Mirallas O, Garcia-Alvarez A, Hernando J, Capdevila J Servei d’Oncologia Mèdica, Unitat de Tumors Gastrointestinals i Endocrins, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Filippi-Arriaga F Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hernandez Hernandez I, Biagetti B Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Aubanell A Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Chaachou A, Martínez-Saez E Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Endocrinology;12; https://doi.org/10.3389/fendo.2021.731631Test; Mirallas O, Filippi-Arriaga F, Hernandez Hernandez I, Aubanell A, Chaachou A, Garcia-Alvarez A, et al. Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report. Front Endocrinol. 2021 Nov 11;12:731631.; https://hdl.handle.net/11351/7615Test; 000727887300001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Serna G, Alonso L, Fasani R, Jimenez J, Nuciforo P Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Ruiz-Pace F, Comas R, Dienstmann R Oncology Data Science Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Hernando J, Elez E, Capdevila J Servei d’Oncologia Mèdica, Unitat de Tumors gastrointestinals i endocrins, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain. Landolfi S Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Tabernero J Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; image/jpeg

    العلاقة: Annals of Oncology;31(10); https://doi.org/10.1016/j.annonc.2020.06.003Test; Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020 Oct;31(10):1366–75.; https://hdl.handle.net/11351/6378Test; 000574680100001

  10. 10
    دورية أكاديمية

    المصدر: Carmona-bayonas , A , Jiménez-fonseca , P , Lamarca , Á , Barriuso , J , Castaño , Á , Benavent , M , Alonso , V , Riesco-martínez , M D C , Alonso-gordoa , T , Custodio , A , Sánchez Cánovas , M , Hernando Cubero , J , López , C , Lacasta , A , Fernández Montes , A , Marazuela , M , Crespo , G , Escudero , P , Diaz , J Á , Feliciangeli , E , Gallego , J , Llanos , M , Segura , Á , Vilardell ....

    وصف الملف: application/pdf